close :

:

Forgotten your password?
 
Pharma Industry News
Printable Version   Email to a friend

Engel Publishing Partners Celebrates Its 25th Year as a Leading Pharmaceutical Information Provider

NEWTOWN, PA, March 9, 2007 – This year, Engel Publishing Partners celebrates its 25th anniversary as a provider of industry-leading products to the pharmaceutical industry. Engel Publishing Partners launched its premier publication, Medical Advertising News (now Med Ad News) on September 15, 1982. 

The original owners of Engel Publishing Partners, Karl and Styli Engel, sought to create a unique publication for pharmaceutical and health-care marketers, an audience that Karl characterized in his inaugural editorial as “one of the best kept secrets throughout the world of marketing.” He promised his readers that the publication would “report the news and events that shape the industry…and…focus on changes, directions, and trends that ultimately…affect your lives.”

Over the past 25 years, Med Ad News has become one of the most widely read and highly respected publications in the industry. A generation of pharmaceutical managers and health-care marketers has come to rely on the publication for need-to-know business and marketing information. Med Ad News’ special reports have set the industry standard for depth of reporting and analysis. Most notably, Med Ad News has demonstrated an abiding commitment to its readers and the industry it serves.

Also in the past quarter decade, Engel Publishing Partners has introduced another magazine, R&D Directions, which is the premier publication reporting on the business of pharmaceutical research and development. Data products introduced by Engel Publishing Partners include:

·        eKnowledgeBase – an online database providing comprehensive information on more than 26,000 records of compounds in development and brands on the market

·        PharmaLive.com eNewsletter Series – free daily and weekly e-mail news briefings that keep pharma professionals current on everything from mergers and acquisitions to the latest compounds in preclinical trials

·        PharmaLive.com Special Reports – reports containing in-depth company, product, and pipeline data compiled by our editors

·        OnDemand Special Reports – specialized PDF reports created by defining wanted criteria from a database of more than 26,000 compounds, brands, and companies

Jim Hannan, CEO & Group Publisher of Engel Publishing Partners, states “Providing accurate, timely, career-enhancing information is a responsibility that we take very seriously, and we deeply appreciate the trust placed in Med Ad News.”

About Engel Publishing Partners

For 25 years, Engel Publishing Partners has been the source that pharmaceutical executives turn to for the information they need to create competitive business strategies. Engel Publishing Partners carries a full product line offering industry-leading publications, informative newsletters, and data-rich interactive products. Through these channels, Engel disseminates original and un-biased content that provides insight into industry trends and events, as well as extensive analysis of companies, products, and pipelines.

###

Latest Pharma Industry News...

Pharma Industry News Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

More News Resources


Most Popular Internet Searches
Latest FDA Drug Alerts
July 17, 2008
Audience: Radiological healthcare professionals, cardiologists, hospital risk managers [Posted 07/17/2008] FDA is updating...
July 16, 2008
Audience: Radiologists, surgeons, hospital risk managers, other healthcare professionals [Posted 07/16/2008] FDA informed...
July 16, 2008
Audience: Pharmacists, hospital risk managers, other healthcare professionals[Posted 07/16/2008] Roxane Laboratories, Inc....
July 14, 2008
Audience: Oncologists, other healthcare professionals[Posted 07/14/2008] Genentech, Inc. informed healthcare professionals of...
More...
Latest Drug Information Updates

Eovist
Eovist (gadoxetate disodium) is a gadolinium-based contrast agent for intravenous use in T1-weighted magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adults with known or suspected focal liver disease.

Evolence
Evolence is a collagen-based structural dermal filler for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds.

Kinrix
Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine] is a combination vaccine for protection against diphtheria, tetanus, pertussis and polio diseases in children.

Durezol
Durezol (difluprednate ophthalmic emulsion) is a topical steroid for the treatment of postoperative ocular inflammation and pain.

PrandiMet
PrandiMet (repaglinide and metformin HCl) is a fixed-dose combination of the fast-acting secretagogue replaglinide (also known as Prandin) and insulin sensitizer, metformin, indicated for the treatment of type 2 diabetes.

Pentacel
Pentacel is a combination vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b in children 6 weeks through 4 years of age.

Trivaris
Trivaris (triamcinolone acetonide) is a glucocorticoid corticosteroid delivered via intravitreal injection for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

Entereg
Entereg (alvimopan) is a peripherally-acting mu opioid receptor antagonist used to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery.

OraVerse
OraVerse is a dental anesthetic reversal agent that accelerates the return to normal sensation and function following dental procedures.

Aplenzin
Aplenzin is a once-daily formulation of bupropion hydrobromide indicated for the treatment of depression in adults.

Cimzia
Cimzia is a PEGylated anti-TNF (tumor necrosis factor) biologic therapy for the treatment of moderately to severely active Crohn’s disease in adults.

Relistor
subcutaneous injection for the treatment of opioid-induced constipation

Treximet
Treximet is the first and only migraine product designed to target multiple mechanisms of migraine by combining a triptan, a class of migraine-specific medicines, and an anti-inflammatory pain reliever in a single tablet.

Patanase
Patanase (olopatadine) is an antihistamine nasal spray for the treatment of symptoms of seasonal allergic rhinitis in adults and adolescents twelve years of age and older.

Lexiscan
Lexiscan (regadenoson) is an A2A adenosine receptor agonist indicated for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging (MPI), a test that detects and characterizes coronary artery disease, in patients unable to undergo adequate exercise stress.

More...